Deep knowledge on
small-molecule drugs and
the 90,000 global patents
covering them

Start your free trial now

Instant access. No credit card. No commitment.

Plans and Pricing

DrugPatentWatch Ultimate Plan Preview

Details for Generic Name: besifloxacin hydrochloride

« Back to Dashboard
Besifloxacin hydrochloride is the generic ingredient in one branded drug marketed by Bausch And Lomb and is included in one NDA. There are seven patents protecting this compound. Additional information is available in the individual branded drug profile pages.

This ingredient has sixty-one patent family members in nineteen countries.

Two suppliers are listed for this compound.

Summary for Generic Name: besifloxacin hydrochloride

Drug Master File Entries: 0
Suppliers: see list2

Pharmacology for Ingredient: besifloxacin hydrochloride

Drug ClassQuinolone Antimicrobial

Clinical Trials for: besifloxacin hydrochloride

Systemic Pharmacokinetics of BOL-303224-A
Status: Completed Condition: Conjunctivitis, Bacterial

Assessment of the Concentrations of Besifloxacin, Moxifloxacin, or Gatifloxacin in the Aqueous Humor of Subjects
Status: Completed Condition: Cataract Extraction

A Study to Investigate the Safety and Efficacy of BOL-303224 in the Treatment of Bacterial Conjunctivitis
Status: Completed Condition: Acute Bacterial Conjunctivitis

Besifloxacin Ophthalmic Suspension Verses Gatifloxacin Ophthalmic Solution in Neonates With Bacterial Conjunctivitis
Status: Terminated Condition: Bacterial Conjunctivitis

2-Site Safety Study of Besivance Versus Vigamox Prophylactically in Routine Cataract Surgery
Status: Completed Condition: Corneal Health; Cataract Surgery

A Comparison of Three Fluoroquinolone Topical Eyedrops in the Treatment of Infectious Corneal Ulcers.
Status: Terminated Condition: Corneal Ulcers

Courtesy of
See more clinical trials for this drug
You have an error in your SQL syntax; check the manual that corresponds to your MySQL server version for the right syntax to use near 'LIMIT 5' at line 4